Anti-Hsp70 antibody [C92F3A-5]
4
(3 Reviews)
|
(47 Publications)
Mouse Monoclonal Hsp70 antibody. Suitable for Flow Cyt, WB, IHC-P and reacts with Human, Mouse, Rat samples. Cited in 47 publications. Immunogen corresponding to Recombinant Fragment Protein within Human HSPA1A aa 400-550.
View Alternative Names
HSP72, HSPA1, HSX70, HSPA1A, Heat shock 70 kDa protein 1A, Heat shock 70 kDa protein 1, Heat shock protein family A member 1A, HSP70-1, HSP70.1, HSP72, HSPA1B, Heat shock 70 kDa protein 1B, Heat shock 70 kDa protein 2, Heat shock protein family A member 1B, HSP70-2, HSP70.2
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Hsp70 antibody [C92F3A-5] (AB47455)
Formalin-fixed, paraffin-embedded human colon carcinoma tissue stained for Hsp70 using ab47455 at 1/1000 dilution in immunohistochemical analysis. Counter stained with hematoxylin.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Hsp70 antibody [C92F3A-5] (AB47455)
ab47455 staining Hsp70 in mouse colon cancer tissue section by Immunohistochemistry (Bouin's fixed paraffin embedded tissue sections). The primary antibody was diluted at 1/100,000. A Fluorophore conjugated goat anti mouse was used as secondary. An antibody amplifier™ system was used for staining.
- WB
Unknown
Western blot - Anti-Hsp70 antibody [C92F3A-5] (AB47455)
All are cancer cell lines.
All lanes:
Western blot - Anti-Hsp70 antibody [C92F3A-5] (ab47455) at 1 µg/mL
Lane 1:
Cell lysate prepared from human A431 cell line
Lane 2:
Cell lysate prepared from human A549 cell line
Lane 3:
Cell lysate prepared from human HCT116 cells line
Lane 4:
Cell lysate prepared from human Hela cell line
Lane 5:
Cell lysate prepared from human HEK293 cell line
Lane 6:
Cell lysate prepared from human HepG2 cell line
Lane 7:
Cell lysate prepared from human HL-60 cell line
Lane 8:
Cell lysate prepared from human HUVEC cell line
Lane 9:
Cell lysate prepared from human Jurkat cell line
Lane 10:
Cell lysate prepared from human MCF7 cell line
Lane 11:
Cell lysate prepared from human PC3 cell line
Lane 12:
Cell lysate prepared from human T98G cell line
Lane 13:
Rat brain tissue lysates
Predicted band size: 70 kDa
false
- WB
AbReview50309****
Western blot - Anti-Hsp70 antibody [C92F3A-5] (AB47455)
All lanes:
Western blot - Anti-Hsp70 antibody [C92F3A-5] (ab47455) at 1/500 dilution
All lanes:
Rat bone (tibia) whole cell lysate at 50 µg
Predicted band size: 70 kDa
false
Image courtesy of an anonymous AbReview
- Flow Cyt
Unknown
Flow Cytometry - Anti-Hsp70 antibody [C92F3A-5] (AB47455)
FACS analysis using ab47455 staining heat shock treated CD3 + CD8 + T cells.
- WB
CiteAb
Western blot - Anti-Hsp70 antibody [C92F3A-5] (AB47455)
Hsp70 western blot using anti-Hsp70 antibody [C92F3A-5] ab47455. Publication image and figure legend from Cheng, Y. C., Huang, C. J., et al., 2016, Sci Rep, PubMed 27444754.
ab47455 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab47455 please see the product overview.
Cell model and expression profiles of HSP27 in neurons differentiated from PDMCs.(A) Cell morphology showing the differentiation of neurons derived from PDMCs. Phase contrast images of PDMCs (left upper panel) and neuron-like cells induced by IBMX (left lower panel). Immunocytochemistry analysis of PDMCs (right upper panel) and differentiated neuron-like cells using anti-NSE antibody (right lower panel). Induced neurons extended neurites and formed synaptic connections with each other (red arrowheads). Scale bar = 100 μm. (B) Temporal expression of HSP27 protein in the study model was profiled using 2D-PAGE. PDMCs were harvested at the indicated time points after treatment with IBMX. The proteins at each time point were profiled using 2-DE-PAGE. Cell extracts (300 μg) from each time point were separately subjected to the 2-DE procedure, and protein spots were visualized with silver staining. The rectangle represents the location of HSP27 in 2D-PAGE images. The HSP27 expression level in each 2-DE-PAGE was selected, marked by a cross and indicated with arrows, showing that the protein expression of HSP27 at different time points decreased after IBMX induction (right panel). (C) qPCR analysis of mRNA expression in the PDMCs after IBMX induction. Each time point was evaluated in five independent experiments. The star indicates statistical significance with p value < 0.05. (D) Immunoblots for HSP27, HSP90, HSP70 and HSPA5 after IBMX induction of PDMCs. Cell extracts (30 μg) were prepared from induced PDMCs at the indicated time points (0, 12, 24 and 48 h). GAPDH was used as an internal control.
false
Related conjugates and formulations (1)
-
519 FITC
FITC Anti-Hsp70 antibody [C92F3A-5]
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Hsp70 operates by stabilizing intermediate states of folding proteins preventing aggregation and facilitating the correct folding process. It often forms a complex with co-chaperones such as Hsp40 and nucleotide exchange factors. This complex is essential for the protein's activity and function. Additionally Hsp70 participates in protein degradation pathways by guiding misfolded proteins to the proteasome for degradation maintaining cellular homeostasis.
Pathways
This molecular chaperone plays significant roles in the heat shock response and unfolded protein response pathways. Hsp70 interacts closely with proteins such as Hsp90 and co-chaperones which together help protect cells from stress-induced damage. The protein also participates in the JAK/STAT signaling pathway influencing cell proliferation and apoptosis. These interactions suggest an integral role in maintaining cellular integrity during stress conditions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (47)
Recent publications for all applications. Explore the full list and refine your search
Journal of cancer research and clinical oncology 151:264 PubMed40971071
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular microbiology 121:1127-1147 PubMed38629786
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 25: PubMed38203414
2024
Applications
Unspecified application
Species
Unspecified reactive species
BMC cancer 23:972 PubMed37828458
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed37834400
2023
Applications
Unspecified application
Species
Unspecified reactive species
EMBO reports 24:e53408 PubMed37530743
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cell science 135: PubMed35543156
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cell science 134: PubMed34085697
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cell science 134: PubMed33674449
2021
Applications
Unspecified application
Species
Unspecified reactive species
PLoS genetics 17:e1008951 PubMed33428620
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com